Literature DB >> 1742485

Differentiation-associated expression of prostaglandin H and thromboxane A synthases in monocytoid leukemia cell lines.

S K Sanduja1, K Mehta, X M Xu, S M Hsu, R Sanduja, K K Wu.   

Abstract

To elucidate the differentiation-associated expression of enzymes catalyzing arachidonic acid metabolism, we measured arachidonate metabolites by reverse-phase high pressure liquid chromatography in monocytoid leukemia (ML-1, THP-1, and U937) and myeloid leukemia (KG-1) cell lines. Undifferentiated ML-1 or THP-1 cells produced trace amounts of eicosanoids via the cyclooxygenase (COX) and lipoxygenase (LOX) pathways. Upon differentiation induced by phorbol ester (phorbol 12-myristate 13-acetate [PMA]), metabolites via the COX pathway were increased by 100-fold in ML-1 and THP-1 cells, while the LOX products remained barely detectable. All the COX metabolites were elevated, but thromboxane A2 (TXA2) formation was threefold higher in ML-1 cells than in THP-1 cells. Similar time-related increases in COX metabolites were observed in THP-1 cells induced to differentiate with retinoic acid. Undifferentiated U937 cells were capable of generating a much higher quantity of COX products than ML-1 or THP-1 cells, but, upon PMA-induced differentiation, COX products were increased by only two-fold to threefold over the undifferentiated cells and the total COX products in differentiated U937 cells were only one-seventh of those produced by differentiated ML-1 or THP-1 cells. KG-1 cells had an entirely different metabolic profile. They produced a large quantity of a metabolite coeluted with prostaglandin D2, and PMA had no effect on inducing changes in arachidonic acid (AA) metabolism. Increased COX metabolite formation in differentiated THP-1 and ML-1 cells was due to an enhanced level of prostaglandin H synthase enzyme mass, as measured by Western blot analysis. The TXA synthase activity was also increased by approximately 100-fold in PMA-induced ML-1 cells and 10-fold in THP-1 cells. These findings indicate that increased expression of prostaglandin H and TXA synthase enzymes is a feature of differentiated monocytoid leukemia cell lines.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1742485

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Gene expression of the human prostaglandin E receptor EP4 subtype: differential regulation in monocytoid and lymphoid lineage cells by phorbol ester.

Authors:  K Mori; I Tanaka; M Kotani; F Miyaoka; T Sando; S Muro; Y Sasaki; O Nakagawa; Y Ogawa; T Usui; S Ozaki; A Ichikawa; S Narumiya; K Nakao
Journal:  J Mol Med (Berl)       Date:  1996-06       Impact factor: 4.599

2.  Regulation of cytosolic phospholipase A2, cyclooxygenase-1 and -2 expression by PMA, TNFalpha, LPS and M-CSF in human monocytes and macrophages.

Authors:  Yan J Jiang; Biao Lu; Patrick C Choy; Grant M Hatch
Journal:  Mol Cell Biochem       Date:  2003-04       Impact factor: 3.396

3.  Activation of human THP-1 cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharide.

Authors:  G I Pérez-Pérez; V L Shepherd; J D Morrow; M J Blaser
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

4.  Structures of prostacyclin synthase and its complexes with substrate analog and inhibitor reveal a ligand-specific heme conformation change.

Authors:  Yi-Ching Li; Chia-Wang Chiang; Hui-Chun Yeh; Pei-Yung Hsu; Frank G Whitby; Lee-Ho Wang; Nei-Li Chan
Journal:  J Biol Chem       Date:  2007-11-21       Impact factor: 5.157

5.  Enhanced prostacyclin synthesis in endothelial cells by retrovirus-mediated transfer of prostaglandin H synthase cDNA.

Authors:  X M Xu; K Ohashi; S K Sanduja; K H Ruan; L H Wang; K K Wu
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

6.  Expression of thromboxane synthase, TBXAS1 and the thromboxane A2 receptor, TBXA2R, in human breast cancer.

Authors:  Gareth Watkins; Anthony Douglas-Jones; Robert E Mansel; Wen G Jiang
Journal:  Int Semin Surg Oncol       Date:  2005-10-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.